SCHEMBL5193854

SCHEMBL5193854

COc1cc(OCCOC(C)=O)ccc1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.51
▸ ALDH1A1 P00352 3/20 0.49
▸ HPGD P15428 1/20 0.49
▸ PPARG P37231 1/20 0.47
▸ PPARA Q07869 1/20 0.47
▸ THRA P10827 1/20 0.45
▸ THRB P10828 1/20 0.45
▸ NPC1 O15118 1/20 0.43
▸ PLA2G2A P14555 1/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ MAPT P10636 3/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ PDE3B Q13370 1/20 0.43
▸ PDE3A Q14432 1/20 0.43
▸ P2RY12 Q9H244 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ PARP15 Q460N3 1/20 0.42
▸ PARP10 Q53GL7 1/20 0.42
▸ LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5193515 0.89 KDM4E (0.56) KDM4EALDH1A1HPGDNPC1MAPT
SCHEMBL5232380 0.87 ALDH1A1 (0.53) KDM4EALDH1A1HPGDPPARGPPARA
SCHEMBL1750021 0.84 PPARG (0.61) KDM4EALDH1A1HPGDPPARGPPARA
SCHEMBL8902012 0.84 THRA (0.54) KDM4EALDH1A1HPGDPPARGPPARA
SCHEMBL11775703 0.84 ALDH1A1 (0.53) KDM4EALDH1A1HPGDPPARGPPARA
SCHEMBL5194255 0.82 MEN1 (0.53) KDM4EALDH1A1NPC1KMT2AMEN1
SCHEMBL10459241 0.82 ALDH1A1 (0.51) KDM4EALDH1A1HPGDPPARGPPARA
SCHEMBL5191841 0.82 PDE3B (0.44) KDM4EALDH1A1THRATHRBL3MBTL1
SCHEMBL29032440 0.82 SLC16A3 (0.54) KDM4EALDH1A1HPGDPPARGPPARA
SCHEMBL5195144 0.82 THRA (0.48) KDM4EALDH1A1HPGDPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070232594-A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both KISSEI PHARMACEUTICAL CO., LTD. (JP) 2007-10-04 — — US disclosed
US-20070232594-A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both KISSEI PHARMACEUTICAL CO., LTD. (JP) 2007-10-04 — — US disclosed
US-20070232594-A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both KISSEI PHARMACEUTICAL CO., LTD. (JP) 2007-10-04 — — US disclosed
EP-1813603-A1 AROMATIC AMIDE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THE SAME, MEDICAL USES OF BOTH Kissei Pharmaceutical Co., Ltd. (JP) 2007-08-01 — — EP disclosed
EP-1813603-A1 AROMATIC AMIDE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THE SAME, MEDICAL USES OF BOTH Kissei Pharmaceutical Co., Ltd. (JP) 2007-08-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232594-A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both AVPR2, AVPR1A, AVPR1B KDM4E 3094/4885ALDH1A1 1557/4885HPGD 974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback